The NEAT Study: A 48-Week Open-Label Study to Compare the Antiviral Efficacy and Safety of GW433908 Versus Nelfinavir in Antiretroviral Therapy-Naive HIV-1-Infected Patients.

Autor: Rodrigeuz-French, Amalia, Boghossian, Jack, Gray, Glenda E., Nadler, Jeffrey P., Quinones, Arnaldo R., Sepulveda, Gladys E., Millard, Judith M., Wannamaker, Paul G.

Publikováno v: JAIDS: Journal of Acquired Immune Deficiency Syndromes; 1/1/2004, Vol. 35 Issue 1, p22-32, 11p, 4 Charts, 6 Graphs